´ëÇÑ´ëÀåÇ×¹®ÇÐȸ International Colorectal Research Summit 2022 (3ÀÏÂ÷) : 2022-09-04±³À°ÀÏÀÚ : 2022-09-04
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼¿ï
±³À°ÁÖÁ¦ :
(¿Â-¿ÀÇÁº´Çà) International Colorectal Research Summit 2022 (3ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ
´ã´çÀÚ : ±è¼ö¿¬
¿¬¶ôó : 02-2040-7737
À̸ÞÀÏ :
colon@kams.or.kr ±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 140,000¿ø
ºñ°í Early Registration: Members KRW 100,000 Military Doctor/Resident KRW 30,000 Nurse KRW 50,000 NON-Members KRW 120,000 / On-site Registration: Members KRW 120,000 Military Doctor/Resident KRW 50,000 Nurse KRW 70,000 NON-Members KRW 140,000 One Day Fee(9/4 or 5) : Early Bird Members KRW 70,000 / On-site Registration NON-Members KRW 80,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-04 room2 08:30~08:50 Resectable Metastasis Colon: Chemotherapy First vs. Surgery First ±è¿µÀÏ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-04 room2 08:50~09:10 Resectable Metastasis Rectum: Is There the Role of Neoadjuvant Short-Course RT? º¯È°æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-04 room2 09:10~09:30 Conversion Strategies for Unresectable Liver Metastases ±èÁö¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-04 room2 09:30~09:50 Management of Disappeared Liver Metastasis ¼Û°æµÎ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09-04 room2 09:50~10:10 Case Presentation ÀÌÁ¾·ü(¿ï»êÀÇ´ë)
ÈÞ½Ä 09-04 room2 10:10~10:40 Break ()
±³À°½Ã°£ 09-04 room2 10:40~11:00 Peritoneal Carcinomatosis in Colorectal Cancer: Biology and Barriers ±èâÇö(Àü³²ÀÇ´ë)
±³À°½Ã°£ 09-04 room2 11:00~11:20 Pharmacokinetics of HIPEC and PIPAC: Is There the Rationale? ¹Úµ¿±¹(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 09-04 room2 11:20~11:40 Lessons Leared PRODIGE 7 ±è¿ì¶÷(Æ÷õÁß¹®ÀÇ´ë)
±³À°½Ã°£ 09-04 room2 11:40~12:00 Cytoreductive Surgery with HIPEC and PIPAC ¹ÚÀºÁ¤(¿¬¼¼ÀÇ´ë)
Åä·Ð 09-04 room2 12:00~12:20 Case Presentation ÀÓ´ë·Î(¼øõÇâÀÇ´ë)
½Ä»ç 09-04 room2 12:20~13:20 ·±Ãµ½ÉÆ÷Áö¾ö ±¹³»¿¬ÀÚ()
±³À°½Ã°£ 09-04 room2 13:20~13:40 Low Anterior Resection Syndrome ±è¹ÎÁ¤(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-04 room2 13:40~14:00 Genitourinary Sequelae in Rectal Cancer Survivors ¹ÚÇöÁØ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-04 room2 14:00~14:20 Chemotherapy and Radiotherapy Related Problems À̼ö¿µ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 09-04 room2 14:20~14:40 Screening of Second Malignancy ¹ÚÁö¼ö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-04 room2 14:40~15:00 Well-being after Colorectal Cancer Treatment ¹é¼¼Áø(°í·ÁÀÇ´ë)
ÈÞ½Ä 09-04 room2 15:00~15:30 Break ()
±³À°½Ã°£ 09-04 room2 15:30~15:50 Primary Tumor Resection Versus Chemotherapy for CRC Unresectable Metastases (JCOG1007 iPACS) Yukihide KANEMITSU(National Cancer Center Hospital Japan)
±³À°½Ã°£ 09-04 room2 15:50~16:10 Open vs Laparoscopic Surgery for Mid/Low Rectal Cancer After LCRT (COREAN Trial) ¹ÚÁö¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-04 room2 16:10~16:30 Systemic Chemotherapy with or without Cetuximab in Resectable CRLM (NEW EPOC Trial) John PRIMROSE(University of Southhampton UK)
±³À°½Ã°£ 09-04 room2 16:30~16:50 Multicenter, Randomized Single-port versus Multiport Laparoscopic Surgery (SIMPLE) Trial in Colon Cancer °º´¸ð(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 09-04 room2 16:50~17:10 Quality of Life after Sphincter Preservation Surgery or Abdominoperineal Resection for Low Rectal Cancer (ASPIRE): A Long-term Prospective, Multicentre, Cohort Study °¼º¹ü(¼¿ïÀÇ´ë)